If you take Wegovy and are considering switching to Mounjaro, understanding how switching from Wegovy to Mounjaro works is important, as the change is not as simple as swapping one dose for another. As a pharmacist, I would always treat this as a prescribing decision rather than a dose-conversion exercise. The two medicines have different dosing schedules, and your prescriber will need to consider your treatment history, side effects and overall health before deciding how to proceed.

Here is what the product licences say about dosing, along with the decisions that need to be made on an individual basis.

Can You Switch From Wegovy To Mounjaro?

Yes, a prescriber can switch you from Wegovy to Mounjaro. However, the MHRA advises speaking to a healthcare professional first, as switching without medical advice may increase side effects or make treatment less effective.

Neither medicine licence provides a dose-conversion schedule for switching from the other. The Pharmaceutical Journal also notes that there is no NICE or MHRA guidance setting out a standard approach to switching between these medicines.

The Wegovy product information advises against combining it with other GLP-1 medicines. This means you should never inject Wegovy and Mounjaro together unless a specific clinical instruction has been given by an appropriately qualified prescriber. Do not arrange the changeover yourself.

What Do The Licences Say About Wegovy And Mounjaro Doses?

Each medicine has its own starting dose, dose increases and maintenance schedule. The table below sets out the licensed dosing information for both medicines. It is a comparison of their individual schedules, not a guide to converting from one dose to another.

Product Active ingredient Starting dose Step increases Maintenance dose Highest licensed dose Half-life
Wegovy injection Semaglutide 0.25 mg weekly Every 4 weeks: 0.5, 1, 1.7, then 2.4 mg 2.4 mg weekly 7.2 mg (for some adults with obesity) About 1 week
Mounjaro Tirzepatide 2.5 mg weekly After 4 weeks to 5 mg, then 2.5 mg steps if needed 5, 10 or 15 mg weekly 15 mg About 5 days

Please do not compare the milligram numbers. The two medicines are measured on different scales.

Why Is There No Simple Dose Conversion?

Semaglutide and tirzepatide are different medicines, and there is no validated dose equivalence between them. Semaglutide acts on the GLP-1 receptor, whereas tirzepatide acts on both GIP and GLP-1 receptors. This difference in how they work is one reason why their doses cannot simply be matched.

The Mounjaro licence specifies a starting dose of 2.5 mg once a week. The dose is increased gradually, partly because gastrointestinal side effects, such as nausea and vomiting, are more common during dose escalation.

Starting at a different dose would therefore need to be an individual prescribing decision, with the clinical reasoning documented. I would be cautious about relying on any online chart that claims to provide an exact equivalent dose for Wegovy and Mounjaro. Such charts can give a misleading impression that switching is more straightforward than it really is.

How Is The Changeover Timed?

Your prescriber decides the timing, because there are two accepted approaches and no single national rule. They may ask for a gap of one to two weeks before your first Mounjaro dose, or start it when your next Wegovy dose is due. A gap is generally preferred after significant side effects, while a same-day switch may suit people who tolerate treatment well.

Semaglutide stays in your circulation for around seven weeks after the last 2.4 mg dose, so some will remain whichever approach is used. Please keep a note of your last Wegovy strength and injection date.

What Should I Expect After Switching?

Switching to Mounjaro means starting a new treatment with its own dosing schedule. You may experience side effects as your body adjusts, particularly when the dose increases.

  • Stomach effects: nausea, vomiting and diarrhoea mainly occur during escalation and ease over time. Our guides on water intake and dietary changes on Mounjaro may help.
  • When to seek medical advice: Mild nausea is common during dose escalation, but severe or persistent abdominal pain, especially if it spreads to your back, needs urgent assessment. Seek medical advice if vomiting persists or you cannot keep fluids down.
  • Contraception: Mounjaro may reduce the pill's effectiveness, so the MHRA advises a barrier method for four weeks after starting and after each dose increase. The Wegovy product information does not anticipate the same effect on the pill, so this may be new to you. See our guide on Mounjaro and the contraceptive pill.
  • Diabetes medicines: tell your prescriber if you take insulin or a sulfonylurea, as low blood sugar can be more likely.
  • Pace of change: pharmacy guidance warns that switching can cause a temporary plateau while you re-titrate. The Mounjaro product information describes a head-to-head trial where tirzepatide produced greater average weight reduction than semaglutide, but averages do not predict your own response.
  • Review point: both licences ask prescribers to decide whether to continue if you have not lost at least 5% of your initial weight after six months, counted from your highest tolerated dose for Mounjaro. Ask how your progress will be judged.

What Should I Do Next?

Before changing from Wegovy to Mounjaro, arrange a review with your prescriber. Having the following information ready will help them assess whether the switch is appropriate and how it should be managed.

  • Your current Wegovy strength and the date of your last injection.
  • Why you want to switch, including any side effects or concerns about your current treatment.
  • All other medicines you take, particularly the contraceptive pill, insulin or sulfonylureas.
  • Any history of pancreatitis or gallstones.
  • Any plans for pregnancy.

Be open about your experience with Wegovy, including how well you have tolerated it and whether your weight loss has slowed. These details can help your prescriber make a more informed decision about your next treatment.

Where Can I Get Advice Before Switching?

If you would like to discuss your options, you can start your consultation with Pharmacy Planet. A UK clinician will review your health information and assess whether treatment is clinically appropriate for you.

If your Wegovy is prescribed by an NHS team, speak to them before making any changes to your treatment. Always obtain prescription medicines through a registered pharmacy, as the MHRA warns against buying GLP-1 medicines from unregulated sellers.

You may also find our comparison of Wegovy and Mounjaro useful when discussing your options with a prescriber.

Frequently Asked Questions

Can I switch from Wegovy to Mounjaro at an equivalent dose?

No. No validated equivalent exists, so please do not choose a dose yourself. Your prescriber will decide your starting dose.

Do I have to start Mounjaro at 2.5 mg?

The licence says Mounjaro starts at 2.5 mg weekly. Any other starting dose is an individual prescribing decision and should be documented.

How long after my last Wegovy dose can I start Mounjaro?

Your prescriber decides. Options include a gap of one to two weeks or a same-day switch, depending on your tolerance and history.

Can I take Wegovy and Mounjaro together?

No. The Wegovy product information advises against combining it with other GLP-1 medicines, and the MHRA warns that switching without advice can increase side effects.

Wegovy vs Mounjaro for weight loss: which is better?

On average, one trial showed greater weight reduction with tirzepatide. Your own response, tolerability, medical history and prescriber judgement matter more than averages.

Does this apply to Wegovy tablets?

Yes. The licences do not describe switching from Wegovy tablets to Mounjaro either, so please speak to your prescriber. Semaglutide also stays in the body for weeks after the last tablet.

What if I have already stopped taking Wegovy?

If you have stopped Wegovy, tell your prescriber about your last dose, previous strength, and how long you have been off treatment. They will advise when to start Mounjaro and which dose is appropriate. Do not restart or switch without medical advice.

This article is for general information and is not medical advice. Do not change, stop or combine prescribed medicines without speaking to your prescriber. Wegovy and Mounjaro are prescription-only medicines and are supplied only after a clinical assessment.

Sources Referenced

  1. MHRA, GLP-1 medicines for weight loss and diabetes: what you need to know (updated 5 February 2026), sections on switching and contraception
  2. electronic medicines compendium, Mounjaro KwikPen Summary of Product Characteristics (updated 8 September 2026), sections 4.2, 4.5, 4.8, 4.9 and 5.1
  3. electronic medicines compendium, Wegovy injection Summary of Product Characteristics (updated 22 September 2026), sections 4.2, 4.5, 4.8 and 5.2
  4. electronic medicines compendium, Wegovy tablets Summary of Product Characteristics (updated 16 June 2026), sections 4.2 and 5.2
  5. Shahid S, Switching between weight-loss medications, The Pharmaceutical Journal (published 24 July 2026, updated 27 July 2026). The author declares she is a clinical trainer for Eli Lilly